Latest News

Bio-Me raises NOK10m

© mcmurryjulie /pixabay.com


by tg

Oslo-based microbiome expert Bio-Me A/S has raised NOK10m in a new funding round.

Both, existing and new investors participated in the financing round, with new investors contributing the majority of the capital. The company said it will use the assets to further progressits clinical pipeline and explore new business opportunities for shorter-term revenue generation. 

The five-year-old company has developed a novel gut microbiome analysis tool in collaboration with Thermo Fisher Scientific, called Precision Microbiome Profiling (PMP™) that offers a targeted qPCR-based approach to microbiome profiling/diagnosis through the analysis of 100 - 200 samples in two hours.

Morten Isaksen, CEO of Bio-Me said that  the company will  position PMP™ as the preferred solution for therapeutic microbiome companies.

Hot of the press: BIOTECH Insight Newsletter

According to the results of the Biotechnology Company Survey 2022 conducted by BIOCOM AG (Berlin), the turnover of the German biotech sector grew...

Commission to establish EU health data space

The EU Commission is set to present a draft law on a "European health data area" this Tuesday, which could be a big thing for digital...

Chinese Huadong snaps up Heidelberg Pharma.

Meat consumption must fall by at least 75 percent

The study from lead author Prof. Dr Matin Qaim reviews the current state of research on various aspects of meat consumption. In addition to the...

Argenx SE to raise €637m

Last December, the Breda-based drugmaker got the green lightfrom the US FDA for its injectible anti-acetylcholin receptor antibody fragment...

TargED Biopharmaceuticals BV raises €39m in Series A financing

Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures  participated in the financing. Seed investors FIRST...

CSL Behring files for MAA of haemophilia B gene therapy

Marburg-based CSL Behring has filed for accelerated EU marketing authorisation of Etranacogene dezaparvovec (EtranaDez), the first haemophilia B gene...